PARP1 and cancer: The observed HDACi-mediated down-regulation of key DNA repair proteins (Figure 7) combined with the high levels of oxidative and replication stress characteristic of many human cancers could have made these cancer cells not only very sensitive to HDACi via DNA repair inhibition but also highly dependent on PARP and therefore extremely sensitive to combined HDACi/PARPi treatment.